Lifevantage (NASDAQ: LFVN) reported Q2 EPS of ($0.07), $0.12 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $53.7 million versus the consensus estimate of $51.17 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.